Close Menu

NEW YORK (GenomeWeb) – Finnish molecular diagnostics firm Mobidiag announced today that it has raised €4.0 million ($4.7 million) in a funding round.

Completed in less than three weeks, the funding round was led by Finnish investment service company Springvest Oy, and supported by more than 200 investors.

The new funding will help Mobidiag scale up the production of its Novodiag instruments and disposable cartridges, in addition to strengthening its global sales and marketing activities.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.